Antibiotic Research UK awards grants to fund research worth £200,000
Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, is delighted to announce that it is funding seven new antibiotic research projects totalling £200,000, the largest sum it has ever awarded through its 2021 Small Research Grants / Career Development Awards scheme. The grants will fund essential academic research in both basic and applied sciences to help prevent another global pandemic, this time caused by antibiotic resistant bacteria.
The grants have been awarded to support seven research projects across the UK including:
- Dr Ryan Hamilton from the Leicester School of Pharmacy, DeMontfort University – Exploring the experiences and support needs of people living with antimicrobial resistance in the UK: A qualitative interview approach.
- Mrs Dora Elkholly from the Royal Veterinary College – Antimicrobial usage in farm animal veterinary practice in the UK: A mixed method approach.
- Dr Monique Andersson, Nuffield Div. Clinical Laboratory Sciences, Oxford University – A multicentre perspective cohort study to improve outcomes of necrotising otitis externa in the UK.
- Professor Lori Snyder, School of Life Science, Pharmacy and Chemistry, Kingston University – Preventing infant blindness using a non-antibiotic alternative.
- Mr Chris L B Graham, School of Life Sciences, University of Warwick – Antibiotic Breaker: The outer membrane and peptidoglycan link as a new antibiotic vulnerability.
- Professor Matthew Todd, School of Pharmacy, UCL – Drug candidates targeting multiple bacterial enzymes.
- Professor Jeff Errington, Centre for Bacterial Cell Biology, Newcastle University – Establishment of methods for discovery of novel antibacterial inhibitors of RodA protein.
Global Ambassador Network
Welcome at the AMR Insights Ambassador Network!
The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).